Literature DB >> 10353410

Characterization of matrix metalloproteinases in human urine: alterations during adolescence.

K M Thrailkill1, S Kumar, C K Rosenberg, K J Auten, J L Fowlkes.   

Abstract

Matrix metalloproteinases (MMPs) are a family of at least 14 zinc-dependent proteinases that have been implicated in matrix turnover under both normal and pathological conditions. Previous studies have shown that several MMPs are produced in various cell types in the kidney, suggesting that MMPs may be involved in renal morphogenesis and remodelling. Using a variety of techniques, including gelatin and casein zymography, gelatin affinity chromatography, immunoblotting, and immunoprecipitation, we have identified the major gelatinases in human urine as MMP-2 and MMP-9. Latent forms of both enzymes were detected in urine, as well as lower molecular mass species of each, consistent with activated forms of MMP-2 and MMP-9. MMP-2 and MMP-9 were also measured in individual human urine samples (n=40). No significant gender differences in MMP concentrations were detected. However, renal MMP expression appeared to be age dependent; the highest average amounts of urine MMP-2 were detected during adolescence, while the converse was true of urine MMP-9. Together, these findings indicate that under normal conditions, human urine contains MMP-2 and/or MMP-9, suggesting that these two MMPs are normally produced within the kidney, where they may regulate normal renal remodelling and matrix homeostasis in an age-specific manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353410     DOI: 10.1007/s004670050597

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Authors:  Kathryn M Thrailkill; Cindy S Moreau; Gael Cockrell; Pippa Simpson; Rajiv Goel; Paula North; John L Fowlkes; Robert C Bunn
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

2.  Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.

Authors:  C J Kleber; A Spiess; J B Kleber; U Hinz; S Holland-Cunz; J Weiss
Journal:  Eur J Pediatr       Date:  2011-12-28       Impact factor: 3.183

3.  Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.

Authors:  Ayan Biswas; Xueliang Pan; Melissa Meyer; Savita Khanna; Sashwati Roy; Gregory Pearson; Richard Kirschner; Patricia Witman; Esteban Fernandez Faith; Chandan K Sen; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2017-06       Impact factor: 4.730

Review 4.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic kidney disease and acute kidney injury: a systematic review of the literature.

Authors:  C L Sampieri; R A Orozco-Ortega
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

5.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

6.  Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

Authors:  Kathryn M Thrailkill; Robert C Bunn; Cynthia S Moreau; Gael E Cockrell; Pippa M Simpson; Hannah N Coleman; J Paul Frindik; Stephen F Kemp; John L Fowlkes
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

7.  Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator.

Authors:  Alfredo Martínez; Hae-Ryong Oh; Edward J Unsworth; Claudia Bregonzio; Juan M Saavedra; William G Stetler-Stevenson; Frank Cuttitta
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

8.  Matrix metalloproteinases in the urine and tissue of patients with juvenile polyps: potential biomarkers for the presence of polyps.

Authors:  Michael A Manfredi; Victor L Fox; David Zurakowski; Jeffery L Kutok; Jonathan N Glickman; Marsha A Moses
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-04       Impact factor: 2.839

9.  Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes.

Authors:  John L Fowlkes; R Clay Bunn; Gael E Cockrell; Lindsey M Clark; Elizabeth C Wahl; Charles K Lumpkin; Kathryn M Thrailkill
Journal:  Exp Diabetes Res       Date:  2011-05-16

10.  Urinary MMP-9/UCr association with albumin concentration and albumin-creatinine-ratio in Mexican patients with type 2 diabetes mellitus.

Authors:  Víctor Gildardo Arcos-Sacramento; Clara Luz Sampieri; Víctor Hugo Sandoval-Lozano; Rubén Arturo Orozco-Ortega; Mariel Alejandra Acuña-Hernández; Jaime Morales-Romero; Magda Elena Hernández-Hernández; Arturo Rodríguez-Hernández
Journal:  PeerJ       Date:  2020-12-16       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.